Mr. Weber brings extensive marketing, commercialization and international business development experience with large multinational and growth stage companies, including Covalon Technologies, Sentinelle Medical, Hologic, Johnson and Johnson, and Christie Digital. At Sentinelle he led Business Development and Marketing, growing the company from start-up revenues to over $18 million in 2.5 years (it was then acquired by Hologic for $105 million).

Ms. Harrington brings 19+ years of experience in the medical device industry, with expertise in regulatory, quality, and clinical studies in the areas of imaging, cardiovascular, infusion pumps, sports medicine and sterilization systems. Stephanie has achieved multiple medical device regulatory approvals, as well as maintained ongoing product registration, in the US, Canada, Europe and Australia.

Mr. Janzen has been involved in the Life Sciences industry for the past 19 years. He currently is the Founder and President of NorthView Ventures, an entity which invests in and provides strategic advisory services to a number of technology companies. Prior, he was President and CEO of Cardiome Pharma, a NASDAQ listed drug development company that raised over $300M from investors and completed over $1Billion in licensing deals during his tenure.

Paul Magnin has been studying and working in medical imaging since 1977. He competed his doctorate at Duke University and spent 17 years as a key contributor to Hewlett-Packard's Ultrasound Imaging business. From 1998 - 2003, Dr. Magnin was the President and CEO of LightLab Imaging. He was then Founder and President of Novelis, a start-up focused on guiding therapy for Interventional Cardiology applications (sold to Volcano Corporation in 2008).

Mr. Goffenberg has expertise in financial management of information technology firms, including Medworkxx Solutions Inc., Philips Lifeline, DWL Incorporated and Delrina Corporation, both before and after its 1995 sale to Symantec Corporation. He has served as a financial partner and business advocate within a varied scope of organizations - and has served in leadership roles throughout trajectories of up to triple revenue growth.